Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $3.58 $6.48 Friday, 10th May 2024 FATE stock ended at $4.08. This is 4.62% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 17.83% from a day low at $3.67 to a day high of $4.33.
90 days $3.58 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
Dec 16, 2022 $14.00 $14.11 $12.94 $13.08 5 375 978
Dec 15, 2022 $14.49 $15.05 $13.91 $14.21 2 257 586
Dec 14, 2022 $16.33 $16.43 $15.21 $15.37 2 144 976
Dec 13, 2022 $17.35 $17.63 $15.35 $16.37 2 856 401
Dec 12, 2022 $16.88 $17.01 $14.84 $16.20 4 890 842
Dec 09, 2022 $19.00 $19.57 $18.71 $18.90 752 484
Dec 08, 2022 $19.42 $19.42 $18.57 $19.12 1 126 692
Dec 07, 2022 $19.01 $19.40 $18.79 $19.10 966 364
Dec 06, 2022 $20.40 $20.73 $19.03 $19.14 1 133 796
Dec 05, 2022 $20.90 $21.10 $20.02 $20.40 1 112 663
Dec 02, 2022 $19.79 $20.93 $19.48 $20.91 1 366 245
Dec 01, 2022 $20.88 $21.47 $19.95 $20.34 836 626
Nov 30, 2022 $19.98 $21.07 $19.41 $20.82 1 423 453
Nov 29, 2022 $19.34 $20.71 $19.13 $19.84 1 420 774
Nov 28, 2022 $19.73 $20.14 $19.11 $19.26 713 695
Nov 25, 2022 $19.42 $19.99 $19.15 $19.83 333 978
Nov 23, 2022 $19.76 $20.74 $19.50 $19.65 813 604
Nov 22, 2022 $19.65 $19.68 $18.86 $19.55 610 202
Nov 21, 2022 $19.68 $20.07 $19.28 $19.40 446 753
Nov 18, 2022 $20.63 $20.63 $19.73 $19.79 569 576
Nov 17, 2022 $20.10 $20.41 $19.66 $19.87 588 714
Nov 16, 2022 $21.92 $22.05 $20.18 $20.50 935 346
Nov 15, 2022 $23.35 $23.96 $21.90 $22.58 747 691
Nov 14, 2022 $22.90 $23.28 $21.85 $22.57 1 382 991
Nov 11, 2022 $20.66 $23.55 $20.53 $23.25 1 402 957
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT